DeNovo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons
Business Model:
Revenue: $16.8M
Employees: 11-50
Address: 14612 Big Basin Way
City: Saratoga
State: CA
Zip: 95070
Country: US
DeNovo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons learned from a history of successful investing and building successful companies. They believed that their unique combination of skills and perspectives could help entrepreneurs to build companies which would have significant clinical impact and generate superior returns. Seven years later, this belief continues to hold true, demonstrated by investment success in selected medical device and biotechnology companies. With $650 million under management, De Novo has made more than 40 investments in medical devices and biotechnology across three funds. They invest in all stages of enterprise development and growth – from early stage to late stage. The unique background of leading companies as entrepreneurs and operating executives from start to exit enables us to advise entrepreneurs and management teams over the full life cycle of the company.
Contact Phone:
+16503291999
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2009 | WaveTec Vision | Series C | 20.1M |
5/2011 | WaveTec Vision | Series D | 15.9M |
5/2007 | WaveTec Vision | Series B | 13M |
4/2011 | Benvenue Medical | Series C | 35.5M |
4/2006 | Bayhill Therapeutics | Venture Round | 15.8M |
6/2014 | Spinal Kinetics | Venture Round | 34M |
1/2006 | Spinal Modulation | Series A | 7M |
3/2010 | Pulmonx | Series C | 0 |
6/2009 | Spiracur | Series B | 20.3M |
1/2012 | Pulmonx | Private Equity Round | 0 |
3/2013 | Avedro | Series D | 0 |
5/2018 | Avedro | Series F | 0 |
4/2012 | EndoGastric Solutions | Venture Round | 0 |
5/2008 | Astute Medical | Series A | 6.3M |
1/2007 | Ovalis | Series B | 0 |
1/2007 | TearScience | Series B | 15.1M |
1/2023 | Milo | Series A | 0 |
5/2005 | Talima Therapeutics | Series A | 1.6M |
11/2009 | EndoGastric Solutions | Series E | 0 |
10/2009 | EndoGastric Solutions | Venture Round | 0 |
6/2012 | EndoGastric Solutions | Venture Round | 0 |
1/2008 | Benvenue Medical | Series B | 15M |
7/2006 | InSound Medical | Series E | 18.9M |
11/2009 | Spinal Modulation | Series C | 27.4M |
2/2008 | InSound Medical | Series E | 11M |
12/2007 | AxoGen | Post-IPO Equity | 12.1M |
7/2007 | CardioMind | Series C | 11M |
6/2012 | Benvenue Medical | Series D | 25M |
6/2014 | Benvenue Medical | Series E | 40M |
4/2003 | iScience Interventional | Series C | 15M |
3/2008 | CardioMind | Venture Round | 22M |
10/2005 | EBR Systems | Series B | 21M |
12/2009 | EBR Systems | Venture Round | 15M |
3/2004 | Spinal Kinetics | Series A | 10M |
2/2009 | SynergEyes | Series C | 0 |
3/2006 | Cartilix | Series B | 6.3M |
4/2010 | Articulinx Inc. | Series B | 10M |
11/2005 | FlowMedica | Series D | 0 |
10/2008 | InSound Medical | Series E | 13M |
11/2007 | Viracta Therapeutics | Series A | 20M |
10/2007 | Vitreoretinal Technologies | Series A | 12M |
4/2010 | Viracta Therapeutics | Series B | 12M |
3/2004 | InSound Medical | Series D | 17.2M |
5/2010 | Astute Medical | Series B | 26.5M |
3/2011 | Astute Medical | Series B | 13M |
3/2003 | iScience Surgical | Series B | 0 |
7/2008 | Sierra Surgical | Series B | 14.5M |
8/2007 | Sierra Surgical | Series A | 7.1M |
11/2005 | Ovalis | Series A | 0 |
3/2012 | Viracta Therapeutics | Series B | 0 |
5/2007 | Pulmonx | Series B | 20M |
8/2001 | MicroVention Terumo | Series C | 12.5M |
10/2005 | PhotoThera | Series B | 19M |
2/2011 | EBR Systems | Series D | 5M |
6/2004 | EBR Systems | Series A | 5.2M |
9/2013 | MyoScience | Series E | 0 |
7/2008 | MyoScience | Series B | 0 |
3/2012 | MyoScience | Series D | 0 |
6/2011 | Spinal Modulation | Series D | 0 |
6/2004 | Paracor Medical | Series C | 30.5M |
9/2011 | Simpirica Spine | Series C | 22M |
6/2007 | Paracor Medical | Series D | 44M |
8/2007 | EndoGastric Solutions | Series D | 30M |
6/2009 | Facet Solutions | Debt Financing | 4.1M |
11/2008 | OncoMed Pharmaceuticals | Series B | 154M |
1/2016 | Benvenue Medical | Equity | 23M |
5/2009 | PhotoThera | Series D | 50M |
5/2014 | EndoGastric Solutions | Series G | 0 |
4/2006 | PhotoThera | Series C | 30.5M |
4/2006 | SynergEyes | Series B | 0 |
5/2007 | Talima Therapeutics | Series B | 19M |
7/2003 | Bacchus Vascular | Series D | 25M |
4/2017 | Avedro | Venture Round | 0 |
5/2007 | TRIA Beauty | Series D | 0 |
5/2009 | iScience Interventional | Series F | 20.5M |
12/2005 | Facet Solutions | Series B | 16.5M |
6/2008 | EBR Systems | Series C | 35M |
1/2006 | Spinal Kinetics | Series B | 36M |
1/2002 | Renovis | Series B | 0 |
5/2005 | Bayhill Therapeutics | Series B | 35.4M |
2/2011 | Spiracur | Series C | 35M |
1/2008 | Avedro | Series A | 8M |
3/2005 | iScience Surgical | Series C | 0 |
4/2012 | WaveTec Vision | Venture Round | 0 |
1/2003 | Lumend | Series D | 23.2M |
1/2008 | POINT Biomedical | Private Equity Round | 0 |
4/2016 | TearScience | Series D | 0 |
9/2009 | Spinal Kinetics | Debt Financing | 5.3M |
2/2011 | TRIA Beauty | Venture Round | 26.3M |
10/2012 | TRIA Beauty | Venture Round | 7.5M |
7/2013 | TRIA Beauty | Private Equity Round | 0 |
1/2012 | iScience Interventional | Venture Round | 2.8M |
5/2010 | TearScience | Series C | 44.5M |
8/2010 | EndoGastric Solutions | Series F | 0 |
6/2009 | EndoGastric Solutions | Venture Round | 3.8M |
6/2012 | Astute Medical | Series C | 40.4M |
5/2018 | Avedro | Series F | 0 |
4/2017 | Avedro | Venture Round | 0 |
4/2016 | TearScience | Series D | 0 |
1/2016 | Benvenue Medical | Series F | 0 |
6/2014 | Benvenue Medical | Series E | 0 |
6/2014 | Spinal Kinetics | Venture Round | 0 |
5/2014 | EndoGastric Solutions | Series G | 0 |
9/2013 | MyoScience | Series E | 0 |
7/2013 | TRIA Beauty | Private Equity Round | 0 |
3/2013 | Avedro | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|